Low-Level Light Therapy Effect on Metabolites Measured by MR Spectroscopy in Patients with Moderate Traumatic Brain Injury: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.

BACKGROUND AND PURPOSE: Low-level light therapy (LLLT) has been shown to modulate recovery in patients with traumatic brain injury (TBI). However, the longitudinal impact of LLLT on brain metabolites has not been studied. The purpose of this study was to use MR spectroscopic imaging to assess the metabolic response of LLLT in patients with moderate TBI at acute (within 1 week), subacute (2-3 weeks), and late-subacute (3 months) recovery phases.

MATERIALS AND

METHODS

This is a secondary analysis of a prospective single-site double-blind sham-controlled study conducted in patients with moderate TBI. Participants were randomized for LLLT and sham treatment. Three-Tesla 2D MR spectroscopic imaging was acquired. Our focus of investigation was the metabolic change in the corpus callosum (CC) and the changes in mIns/NAA, representing the combined effect of elevated neuroinflammation (mIns) and decreased neuronal/axonal health (NAA). A linear mixed-effects model was constructed to quantify the association between mIns/NAA and treatment, scan, and the interaction between treatment and scan.

RESULTS

Thirty-four participants (18 men, age 49 ± 17 [range, 20-79]; 15 LLLT, 19 sham) were included in the final data set and were scanned at the following time points: acute (n=24), subacute (n=27), and late subacute (n=23). The mIns/NAA ratio in the CC of the sham-treated participants increased over time. Sham-treated participants revealed a significant increase in mIns/NAA from the acute to the late subacute phases (0.19; 95% CI, 0.09-0.29; P Holm = .005). mIns/NAA stayed relatively stable in participants undergoing LLLT treatment (all P Holm > .64). Consequently, mIns/NAA was significantly higher in the sham-treated participants compared with the LLLT-treated participants during the late subacute phase of recovery (-0.31; 95% CI, -0.50 to -0.12; P Holm = .019).

CONCLUSIONS

Despite the small sample size, MR spectroscopic imaging indicates a metabolic response in participants treated with LLLT compared with those receiving sham treatment. This potentially suggests a neuroprotective and anti-inflammatory effect from the acute administration of LLLT in individuals with moderate TBI.